Objective To investigate the intervention effect and mechanism of Suanzaoren decoction(SZRD)on insomnia and depression model mice based on pharmacodynamics and network pharmacology.Methods According to the insomnia disease model,the mice were randomly divided into control,insomnia model,SZRD low-dose,high-dose and diazepam groups;according to the depression disease model,the mice were randomly divided into control,depression model,SZRD low-dose,high-dose and Xiaoyao pill groups.The contents of 5-hydroxytryptamine(5-HT),norepinephrine(NE),and dopamine(DA)in the brains of mice were measured on days 7 and 28,and behavioral evaluations were performed in each group of mice.With the help of network pharmacology method to predict the key targets and related pathways of Suanzaoren decoction in the treatment of insomnia and depression,and to explore its mechanism.Results Behavioral tests and neurotransmitter content determination showed that SZRD could prolong sleep time(P<0.05),improve insomnia behavioral performance in model mice(P<0.05),reduce NE and DA contents in brain tissue of insomnia mice,increase 5-HT content(P<0.05),and was more significant in the low-dose group(P<0.05);SZRD could improve depression behavioral performance,increase sugar water preference,and reduce immobility time in model mice(P<0.05,P<0.01),and increase NE,DA,and 5-HT contents in brain tissue of depression mice(P<0.05),and was more significant in the high-dose group(P<0.05).18 core targets of SZRD in the treatment of insomnia and 34 core targets in the treatment of depression were predicted with the help of network pharmacology methods,and gene ontology(GO)functional analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway analysis showed that SZRD mainly involved biological processes such as dopamine neurotransmitter receptor activity,synaptic transmission and cellular response to reactive oxygen species,and acted on pathways such as the cGMP-PKG signaling pathway and IL-17 signaling pathway to exert therapeutic effects.Conclusion The changes of NE,DA and 5-HT contents in insomnia and depression model mice are not consistent,and the intervention effect of Suanzaoren decoction is also different.Low and high doses of Suanzaoren decoction can exert the best therapeutic effect on insomnia and depression model mice,respectively,and its promoting sleep and antidepressant effects may be related to the cGMP-PKG signaling pathway and IL-17 signaling pathway.

Objective:To investigate the effect of 980 nm semiconductor laser preablation of urethra mucosa at the prostatic tip in small volume benign prostatic hyperplasia (BPH).Methods:The case data of 120 patients diagnosed with small volume BPH in the Yan′an University Affiliated Hospital from June 2020 to June 2022 were retrospectively analyzed, and they were divided into improved group and conventional group according to different treatment methods, with 60 cases in each group. Patients in the improved group were treated with 980 nm semiconductor laser preablation of urethra mucosa at the prostatic tip, and patients in the conventional group were treated with 980 nm semiconductor laser vaporization of prostate. The sexual function of the patients was evaluated by the international erectile function index-5(IIEF-5) score, erectile hardness score (EHS) and retrograde ejaculation before surgery and 1, 3, 6, and 12 months after surgery. International prostate symptom scale (IPSS), quality of life (QOL) score, the maximum urine flow rate (Qmax) and postvoid residual urine (PVR) were used to evaluate urinary control function. The incidence of urinary incontinence, bladder neck contracture and other complications were compared between the two groups. Measurement data were expressed as mean±standard deviation ( ± s), and t-test was used for comparison between groups. The count data were expressed as cases and percentage, and Chi-square test was used for comparison between groups. Results:There was no significant difference in PVR, Qmax, IPSS score, QOL score, IIEF-5 score and EHS score between two groups ( P>0.05). In terms of PVR, Qmax, IPSS score, QOL score, IIEF-5 score and EHS score at 1, 3, 6 and 12 months after surgery, all these parameters were significantly improved compared with the preoperative, the differences were statistically significant ( P< 0.05). However, there was no significant difference between the two groups ( P> 0.05). There was no significant difference in IIEF-5 score and EHS score between the two groups during postoperative follow-up and before and after operation ( P> 0.05). The incidence of retrograde ejaculation rate in the improved group was lower than that in the conventional group during the follow-up 1, 3, 6 months after surgery, and the difference was statistically significant ( P<0.05). In the follow-up 1, 3 months after surgery, the incidence of stress urinary incontinence in the improved group was lower than that in the conventional group, the differences were statistically significant ( P< 0.05). At follow-up 6, 12 months after surgery, the rates of stress urinary incontinence were similar between the two groups, and the difference was not statistically significant ( P> 0.05). In the follow-up 12 months after surgery, there were 2 cases (3.33%) of bladder and neck contracture in the improved group, and 8 cases (13.33%) in the conventional group, the difference was statistically significant ( P<0.05). Conclusions:The effect of 980 nm semiconductor laser preablation of urethra mucosa at the prostatic tip in small volume BPH patients is similar to that of conventional vaporization, and the operation time is short. At the same time, the proximal 1 cm tissue of the verticulae and the integrity of the bladder neck are preserved, and the internal and external sphincter of the urethra are protected, thus improving the immediate postoperative urinary control rate and the incidence of retrograde ejaculation in small volume BPH patients.

Objective:To evaluate the detection ability of two kinds of high-throughput method to determine neutralizing antibodies based on a microneutralization test (MNT).Methods:Serum samples were collected from the early phase and follow-up period (117 samples in total) for neutralizing antibody testing. They were tested using MNT, pseudovirus neutralization assay (PBNA), competitive inhibition assay (including enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA)) to evaluate the correlation coefficients and threshold values for the effectiveness of these high-throughput neutralizing antibody assays.Results:The correlation coefficients for PBNA, ELISA, and CLIA relative to MNT were 0.760, 0.778, and 0.725, respectively, for individuals infected with 2019-nCoV. The area under the ROC curve was 0.901 for a cutoff value of 50 for the PBNA assay, 0.934 for a cutoff value of 1∶8 for the ELISA assay and 0.838 for a cutoff value of 1.28AU/ml for the CLIA assay when the threshold value for the microneutralization test was taken as 1: 10 (less than 1: 10 is considered negative).Conclusions:The high-throughput method for the detection of COVID-19 neutralizing antibodies are scientific and feasible, and provide an important technical tool for the regular prevention and control of the epidemic.